Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women

American Journal of Epidemiology

Volumn 144, Issue 7, 1996, Pages 645-652

  Calle, Eugenia E ^a   Mervis, Cynthia A ^a   Thun, Michael J ^a   Rodriguez, Carmen ^a   Wingo, Phyllis A ^a   Heath Jr , Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

breast neoplasms; cohort studies; diethylstilbestrol; risk

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT;

EID: 0029785632     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008976     Document Type: Article

References (50)

1. Marselos M, Tomatis L. Diethylstilboestrol: pharmacology, toxicology, and carcinogenicity in humans. Eur J Cancer 1992;28A:1182-9.
2. Smith OW. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Obstet Gynecol 1948; 56:821-34.
3. Smith OW, Smith G, Van S. The influence of diethylstilbestrol on the progress and outcome of pregnancy based on a comparison of treated with untreated primigravidas. Am J Obstet Gynecol 1949;58:994-1009.
4. Noller KL, Fish CR. Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am 1974;58:793-810.
5. Noller KL, Decker DG, Lanier AP, et al. Clear cell adenocarcinoma of the cervix after maternal treatment with synthetic estrogens. Mayo Clin Proc 1972;47:629-30.
6. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284: 878-81.
7. Herbst AL, Cole P, Colton T, et al. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 1977;128:43-50.
8. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.
9. Dieckmann WJ, Davis ME, Rynkiewicz SM, et al. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 1953;66:1062-75.
10. Ferguson JH. Effect of stilbestrol on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol 1953;65: 592-601.
11. Swyer GIM, Law RG. An evaluation of the prophylactic antenatal use of stilbestrol. Preliminary report. J Endocrinol 1954;10:vi.
12. Conference of Diabetes and Pregnancy. The use of hormones in the management of pregnancy in diabetics. Lancet 1955;2: 833-6.
13. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas. Cancer 1970;25:745-57.
14. Greenwald P, Barlow JJ, Nasca PC, et al. Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 1971;285:390-2.
15. Henderson BE, Benton BDA, Weaver PT, et al. Stilbestrol and urogenital tract cancer in adolescents and young adults. N Engl J Med 1973;288:354.
16. Bibbo M, Haenszel WM, Wied GL, et al. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med 1978;298:763-7.
17. Hubby MM, Haenszel WM, Herbst AL. Effects on the mother following exposure to diethylstilbestrol during pregnancy. In: Herbst AL, Bern HA, eds. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, 1981:120-8.
18. Beral V, Colwell L. Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers. Br Med J 1980;281:1098-101.
19. Vessey MP, Fairweather DVI, Norman-Smith B, et al. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol 1983;90:1007-17.
20. Meara J, Vessey M, Fairweather DV. A randomized double-blind controlled trial of the value of diethylstilboestrol therapy in pregnancy: 35-year follow-up of mothers and their offspring. Br J Obstet Gynaecol 1989;96:620-2.
21. Hadjimichael OC, Meigs JW, Falcier FW, et al. Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst 1984;73:831-4.
22. Greenberg ER, Barnes AB, Resseguie L, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 1984;311:1393-8.
23. Colton T, Greenberg ER, Noller K, et al. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. JAMA 1993;269:2096-100.
24. Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. Monogr Natl Cancer Inst 1985;67:49-52.
25. Stellman SD, Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 1986;76:1057-63.
26. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993;137:235-41.
27. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Vol 1. Ninth Revision. Geneva: World Health Organization, 1977.
28. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold Company, 1982.
29. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, Inc, 1980.
30. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972;34:187-220.
31. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
32. Pike MC, Henderson BE, Casagrande JT, et al. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 1981;43:73-6.
33. Hadjimichael OC, Boyle CA, Meigs JW. Abortion before first live birth and risk of breast cancer. Br J Cancer 1986;53: 281-4.
34. Nishiyama F. The epidemiology of breast cancer in Tokushima prefecture, Japan. (In Japanese). Shikoku Acta Med 1982;38:333-43.
35. Lubin JH, Burns PE, Blot WJ, et al. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst 1982;68:211-17.
36. Brinton LA, Hoover R, Fraumeni JF. Reproductive factors in the aetiology of breast cancer. Br J Cancer 1983;47:757-62.
37. Lé MG, Bachelot A, Doyon F, et al. Oral contraceptive use and breast or cervical cancer: preliminary results of a French case-control study. In: Hormones and sexual factors in human cancer aetiology. Amsterdam: Exerpta Medica, 1984:139-47.
38. LaVecchia C, Decarli A, Parazzini F, et al. General epidemiology of breast cancer in northern Italy. Int J Epidemiol 1987;16:347-55.
39. Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 1988;58: 99-104.
40. Rosenberg L, Palmer JR, Kaufman DW, et al. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 1988;127:981-9.
41. Howe HW, Senie RT, Bzduch H, et al. Early abortion and breast cancer risk among women under age 40. Int J Epidemiol 1989;18:300-5.
42. Adami HO, Bergstrom E, Lund E, et al. Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway. Br J Cancer 1990;62:122-6.
43. Parazzini F, LaVecchia C, Negri E. Spontaneous and induced abortion and risk of breast cancer. Int J Cancer 1991;48: 816-20.
44. Sellers T, Potter JD, Severson RK, et al. Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study. Cancer Causes Control 1993;4:21-8.
45. Andrieu N, Clavel F, Gairard B, et al. Familial risk of breast cancer and abortion. Cancer Detect Prev 1994;18:51-5.
46. Daling JR, Malone KE, Voigt LF, et al. Risk of breast cancer associated with induced abortion. J Natl Cancer Inst 1994;86: 1584-92.
47. Calle EE, Mervis CA, Wingo PA, et al. Spontaneous abortion and risk of fatal breast cancer in a prospective cohort of United States women. Cancer Causes Control 1995;6:460-8.
48. International Agency for Research on Cancer (IARC). Sex hormones (II). In: IARC monographs on the evaluation of carcinogenic risks to humans. Vol 21. Lyon, France: IARC, 1979:43.
49. International Agency for Research on Cancer (IARC). Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. In: IARC monographs on the evaluation of carcinogenic risks to humans. Suppl 7. Lyon, France: IARC, 1987:273-8.
50. Diethylstilbestrol. ACOG committee opinion: Committee on Gynecologic Practice. Number 131 - December 1993. Int J Gynaecol Obstet 1994;44:184.